Pfizer PF-06688992 in Patients With Stage III or Stage IV Melanoma
Clinical trial NCT03159117 · COMPLETED
Trial details
- NCT number
- NCT03159117
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-05-16
- Primary completion
- 2020-01-10
- Enrollment
- 7
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.